The Medical Device Industry: How It Works and Where It's Heading

The medical device industry, usually shortened to MedTech, covers every company that designs, makes and sells the products used to diagnose, monitor and treat patients, from tongue depressors to implanted neurostimulators, imaging systems and diagnostic software. It is regulated differently from pharmaceuticals, sold differently and staffed differently, and that shapes everything from how products launch to who companies need to hire.

What counts as a medical device

In the United States, a medical device is a product intended to diagnose, prevent, monitor or treat disease that achieves its purpose without working chemically in the body the way a drug does. The definition is broad. It covers hardware, in vitro diagnostic tests and, increasingly, software on its own: software as a medical device.

How devices reach the US market

The FDA sorts devices into three classes by risk, and the class largely decides the route to market:

• Class I, lowest risk: most are exempt from premarket review and rely on general controls such as registration, labeling and good manufacturing practice.
• Class II, moderate risk: most reach the market through premarket notification, the 510(k), by showing the device is substantially equivalent to one already legally marketed. Novel moderate-risk devices with no equivalent can use the De Novo pathway.
• Class III, highest risk: these usually need premarket approval, which requires clinical evidence of safety and effectiveness.

Quality rules apply across all three. On February 2, 2026, the FDA's Quality Management System Regulation took effect, aligning US quality system requirements with the international standard ISO 13485. In Europe, manufacturers continue to work through the transition to the Medical Device Regulation and the In Vitro Diagnostic Regulation, which raised evidence and documentation requirements for many products already on the market.

How devices are sold

Device sales rarely look like a single transaction. A new product may need a physician champion, a hospital value analysis committee's approval, a group purchasing contract and a payer willing to reimburse the procedure. Representatives and clinical specialists often support cases in the procedure room. That's why MedTech commercial teams combine sales, clinical, market access and national accounts roles, and why experience in a specific clinical area carries so much weight.

The trends reshaping the industry

AI moves into the device

The FDA keeps a public list of AI-enabled devices it has authorized, and it has grown quickly, led by radiology. Regulators are adapting too: the FDA's guidance on predetermined change control plans lets manufacturers get approval in advance for planned updates to AI models, rather than filing a new submission each time.

Robotics spreads

Robotic-assisted surgery has moved from a single dominant system toward a crowded field across general surgery, orthopedics, urology and more. The FDA cleared Intuitive's fifth-generation da Vinci system in 2024, and newer competitors keep arriving.

Care moves out of the hospital

Continuous monitoring, remote patient monitoring and home-based care are shifting where devices are used. In 2024 the FDA cleared the first continuous glucose monitors sold without a prescription, and consumer technology companies now hold FDA authorizations for health features on watches.

Devices that adjust themselves

Closed-loop systems sense the body and adjust therapy in response, from automated insulin delivery to adaptive deep brain stimulation, which received FDA approval in 2025.

Consolidation

Large manufacturers continue to buy smaller innovators to fill gaps in their portfolios, which shapes the market for both start-up and enterprise talent.

What it means for MedTech hiring

Each trend changes who companies need:

• Software, data and cybersecurity skills now sit alongside traditional mechanical and electrical engineering.
• Regulatory and quality professionals who understand software as a medical device, AI and the new quality regulation are in short supply.
• Clinical and medical affairs teams generate the evidence that higher-risk products and payers demand.
• Commercial teams need to sell value and outcomes to buying committees, not just features to physicians.

The common thread is that MedTech roles increasingly combine skills that used to sit in separate departments, and the people who have them are rarely on the job market.

FloodGate Medical is a retained search firm specializing exclusively in MedTech. Since 2001, we've helped companies build teams across commercial, clinical, regulatory, quality and operations functions. See the specialties we recruit in and our MedTech Compensation Guide.